PAPER Shirane M
SEARCH RESULTS
18454 RESULTS
PAPER Iyer S, Bhat I, Bangera Sheshappa M
Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases.
Mol Nutr Food Res. 2024 Jul;68(13):e2300409. Epub 2024 Mar 15 PubMed.PAPER Sewell KR, Rainey-Smith SR, Pedrini S, Peiffer JJ, Sohrabi HR, Taddei K, Markovic SJ, Martins RN, Brown BM
The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults.
Geroscience. 2024 Mar 15; PubMed.PAPER Liao W, Wei J, Liu C, Luo H, Ruan Y, Mai Y, Yu Q, Cao Z, Xu J, Zheng D, Sheng Z, Zhou X, Liu J
Magnesium-L-threonate treats Alzheimer's disease by modulating the microbiota-gut-brain axis.
Neural Regen Res. 2024 Oct 1;19(10):2281-2289. Epub 2023 Dec 21 PubMed.PAPER Mugundhan V, Arthanari A, Parthasarathy PR
Protective Effect of Ferulic Acid on Acetylcholinesterase and Amyloid Beta Peptide Plaque Formation in Alzheimer's Disease: An In Vitro Study.
Cureus. 2024 Feb;16(2):e54103. Epub 2024 Feb 13 PubMed.PAPER Steiner MA
Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
NPJ Parkinsons Dis. 2024 Mar 14;10(1):59. PubMed.PAPER Price DL, Khan A, Angers R, Cardenas A, Prato MK, Bani M, Bonhaus DW, Citron M, Biere AL
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
NPJ Parkinsons Dis. 2024 Mar 14;10(1):60. PubMed.PAPER Kieu C, Look KA
Cost-Effectiveness of a Hypothetical Gene Therapy for Alzheimer's Disease: A Markov Simulation Analysis.
Innov Pharm. 2023;14(3) Epub 2023 Nov 9 PubMed.PAPER Wang Y, Chen J, Wang C, Chen T, He L
GW9508 ameliorates cognitive dysfunction via autophagy pathway in streptozotocin-induced mouse model of Alzheimer's disease.
Fundam Clin Pharmacol. 2024 Mar 14; PubMed.PAPER Costanzo M, Aiello F, Poleggi A, Li Voti P, Fabbrini G, Belvisi D
Progressive supranuclear palsy phenotype as an atypical clinical presentation of Creutzfeldt-Jakob disease: A case report and review of the literature.
Clin Park Relat Disord. 2024;10:100247. Epub 2024 Mar 5 PubMed.PAPER Perales-Puchalt J, Peltzer J, Fracachan-Cabrera M, Perez GA, Ramírez M, Greiner KA, Burns JM
Impact of the COVID-19 Pandemic on Latino Families With Alzheimer Disease and Related Dementias: Qualitative Interviews With Family Caregivers and Primary Care Providers.
JMIRx Med. 2024 Mar 8;5:e42211. PubMed.PAPER Wang X, Jacobs D, Salmon DP, Feldman HH, Edland SD
Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials.
Int J Stat Med Res. 2023 Feb 15;12:90-96. Epub 2023 Sep 7 PubMed.PAPER Cortes-Flores H, Torrandell-Haro G, Brinton RD
Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseases.
Front Psychiatry. 2024;15:1358568. Epub 2024 Feb 29 PubMed.PAPER Loreto F, Verdi S, Kia SM, Duvnjak A, Hakeem H, Fitzgerald A, Patel N, Lilja J, Win Z, Perry R, Marquand AF, Cole JH, Malhotra P
Alzheimer's disease heterogeneity revealed by neuroanatomical normative modeling.
Alzheimers Dement (Amst). 2024;16(1):e12559. Epub 2024 Mar 13 PubMed.PAPER Park HH, Kim BH, Leem SH, Park YH, Chung H, Yoo DH, Park I, Nam Y, Kim S, Shin SJ, Moon M
Therapeutic Potential of Traditional Oriental Medicines in Targeting Tau Pathology: Insights from Cell-free and Cell-based Screening.
Curr Med Chem. 2024 Mar 13; PubMed.Current Filters
- Date Range : Mar 2024 to Mar 2025 x